1416PImmunosenescence (iSenescence) correlates with disease progression in advanced non-small cell lung cancer (aNSCLC) patients treated with PD-(L)1 inhibitors (IO). (23rd October 2018) - Ferrara, R; Naigeon, M; Auclin, E; Duchemann, B; Cassard, L; Medhi, J; Boselli, L; Grivel, J; Desnoyer, A; Mezquita, L; Aboubakar, F; Hendriks, L; et al.